|
1
|
Müller-Höcker J and Rellecke P: Chief cell
proliferation of the gastric mucosa mimicking early gastric cancer:
An unusual variant of fundic gland polyp. Virchows Arch.
442:496–500. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Matsukawa A, Kurano R, Takemoto T,
Kagayama M and Ito T: Chief cell hyperplasia with structural and
nuclear atypia: A variant of fundic gland polyp. Pathol Res Pract.
200:817–821. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tsukamoto T, Yokoi T, Maruta S, Kitamura
M, Yamamoto T, Ban H and Tatematsu M: Gastric adenocarcinoma with
chief cell differentiation. Pathol Int. 57:517–522. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
WHO Classification of Tumours Editorial
Board. WHO classification of tumours. Digestive system tumours 5th
edition. Lyon, IARC Press, 83, 2019.
|
|
5
|
Tohda G, Osawa T, Asada Y, Dochin M and
Terahata S: Gastric adenocarcinoma of fundic gland type: Endoscopic
and clinicopathological features. World J Gastrointest Endosc.
89:244–251. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chan K, Brown IS, Kyle T, Lauwers GY and
Kumarasinghe MP: Chief cell-predominant gastric polyps: A series of
12 cases with literature review. Histopathology. 68:825–833.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ushiku T, Kunita A, Kuroda R,
Shinozaki-Ushiku A, Yamazawa S, Tsuji Y, Fujishiro M and Fukayama
M: Oxyntic gland neoplasm of the stomach: Expanding the spectrum
and proposal of terminology. Mod Pathol. 33:206–216.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chen O, Shao ZY, Qiu X and Zhang GP:
Multiple gastric adenocarcinoma of fundic gland type: A case
report. World J Clin Cases. 7:2871–2878. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nomura R, Saito T, Mitomi H, Hidaka Y, Lee
SY, Watanabe S and Yao T: GNAS mutation as an alternative mechanism
of activation of the Wnt/β-catenin signaling pathway in gastric
adenocarcinoma of the fundic gland type. Hum Pathol. 45:2488–2496.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chiba T, Kato K, Masuda T, Ohara S, Iwama
N, Shimada T and Shibuya D: Clinicopathological features of gastric
adenocarcinoma of the fundic gland (chief cell predominant type) by
retrospective and prospective analyses of endoscopic findings. Dig
Endosc. 28:722–730. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fujii M, Uedo N, Ishihara R, Aoi K,
Matsuura N, Ito T, Yamashina T, Hanaoka N, Takeuchi Y, Higashino K,
et al: Endoscopic features of early stage gastric adenocarcinoma of
fundic gland type (chief cell predominant type): A case report.
Case Rep Clin Pathol. 2:17–22. 2015.
|
|
12
|
Fukatsu H, Miyoshi H, Ishiki K, Tamura M
and Yao T: Gastric adenocarcinoma of fundic gland type (chief cell
predominant type) treated with endoscopic aspiration mucosectomy.
Dig Endosc. 23:244–246. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Imagawa A and Sano N: Gastric
adenocarcinoma of the fundic gland (chief cell predominant type)
with brownish pigmentation. Gastrointest Endosc. 87:1358–1359.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ueyama H, Matsumoto K, Nagahara A, Hayashi
T, Yao T and Watanabe S: Gastric adenocarcinoma of the fundic gland
type (chief cell predominant type). Endoscopy. 46:153–157.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
WHO Classification of Tumours Editorial
Board. WHO classification of tumours. Digestive system tumours 5th
edition. Lyon, IARC Press, 92, 2019.
|
|
16
|
Lee TI, Jang JY, Kim S, Kim JW, Chang YW
and Kim YW: Oxyntic gland adenoma endoscopically mimicking a
gastric neuroendocrine tumor: A case report. World J Gastroenterol.
21:5099–5104. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Miyazawa M, Matsuda M, Yano M, Hara Y,
Arihara F, Horita Y, Matsuda K, Sakai A and Noda Y: Gastric
adenocarcinoma of fundic gland type: Five cases treated with
endoscopic resection. World J Gastroenterol. 21:8208–8214.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ueo T, Yonemasu H and Ishida T: Gastric
adenocarcinoma of fundic gland type with unusual behavior. Dig
Endosc. 26:293–294. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Okumura Y, Takamatsu M, Ohashi M, Yamamoto
Y, Yamamoto N, Kawachi H, Ida S, Kumagai K, Nunobe S, Hiki N and
Sano T: Gastric adenocarcinoma of fundic gland type with aggressive
transformation and lymph node metastasis: A case report. J Gastric
Cancer. 18:409–416. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cancer genome atlas research network.
Comprehensive molecular characterization of gastric adenocarcinoma.
Natrue. 513:202–209. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kong F, Yao Y, Deng R, Li X and Jia Y:
Hopes and failures in front-line advanced HER2-positive gastric
cancer therapy. Anticancer Drugs. 32:675–680. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li J, Lupat R, Amarasinghe KC, Thompson
ER, Doyle MA, Ryland GL, Tothill RW, Halgamuge SK, Campbell IG and
Gorringe KL: CONTRA: Copy number analysis for targeted
resequencing. Bioinformatics. 28:1307–1313. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen K, Wallis JW, McLellan MD, Larson DE,
Kalicki JM, Pohl CS, McGrath SD, Wendl MC, Zhang Q, Locke DP, et
al: BreakDancer: An algorithm for high-resolution mapping of
genomic structural variation. Nat Methods. 6:677–681.
2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu Z, Jiang X, Qin L, Deng H, Wang J, Ren
W, Li H, Zhao L, Liu H, Yan H, et al: A novel UBE2T inhibitor
suppresses Wnt/β-catenin signaling hyperactivation and gastric
cancer progression by blocking RACK1 ubiquitination. Oncogene.
40:1027–1042. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee SY, Saito T, Mitomi H, Hidaka Y,
Murakami T, Nomura R, Watanabe S and Yao T: Mutation spectrum in
the Wnt/β-catenin signaling pathway in gastric fundic
gland-associatedneoplasms/polyps. Virchows Arch. 467:27–38.
2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hidaka Y, Mitomi H, Saito T, Takahashi M,
Lee SY, Matsumoto K, Yao T and Watanabe S: Alteration in the
Wnt/beta-catenin signaling pathway in gastric neoplasias of fundic
gland (chief cell predominant) type. Hum Pathol. 44:2438–2448.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Murakami T, Mitomi H, Yao T, Saito T,
Shibuya T and Watanabe S: Epigenetic regulation of Wnt/β-catenin
signal-associated genes in gastric neoplasia of the fundic gland
(chief cell-predominant) type. Pathol Int. 67:147–155.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kushima R, Sekine S, Matsubara A,
Taniguchi H, Ikegami M and Tsuda H: Gastric adenocarcinoma of the
fundic gland type shares common genetic and phenotypic features
with pyloric gland adenoma. Pathol Int. 63:318–325. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tajima Y, Murakami T, Saito T, Hiromoto T,
Akazawa Y, Sasahara N, Mitomi H, Yao T and Watanabe S: Distinct
involvement of the sonic hedgehog signaling pathway in gastric
adenocarcinoma of fundic gland type and conventional gastric
adenocarcinoma. Digestion. 96:81–91. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ueyama H, Yao T, Akazawa Y, Hayashi T,
Kurahara K, Oshiro Y, Yamada M, Oda I, Fujioka S, Kusumoto C, et
al: Gastric epithelial neoplasm of fundic-gland mucosa lineage:
Proposal for a new classification in association with gastric
adenocarcinoma of fundic-gland type. J Gastroenterol. 56:814–828.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bhaskar Rao D, Panneerpandian P,
Balakrishnan K and Ganesan K: YY1 regulated transcription-based
stratification of gastric tumors and identification of potential
therapeutic candidates. J Cell Commun Signal. 15:251–267.
2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Peng X, Shi J, Zhao Z, Tong R, Zhang X and
Zhong L: Emetine, a small molecule natural product, displays potent
anti-gastric cancer activity via regulation of multiple signaling
pathways. Cancer Chemother Pharmacol. 91:303–315. 2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sun WW, Zhang L, Gu MM, Zhang YQ, Qiu CM
and Da Q: Gastric adenocarcinoma of the fundic gland type:
Clinicopathological analysis of six cases. Zhonghua Bing Li Xue Za
Zhi. 49:343–347. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
34
|
Jing F, Xudan Y, Juan L, Lei W, Xiao H,
Xiang L, Hong Z and Gang X: Two cases of adenocarcinoma of the
gastric fundus and literature review. J Clin Exp Pathol.
36:455–457. 2020.(In Chinese).
|
|
35
|
Matsubara A, Sekine S, Kushima R, Ogawa R,
Taniguchi H, Tsuda H and Kanai Y: Frequent GNAS and KRAS mutations
in pyloric gland adenoma of the stomach and duodenum. J Pathol.
229:579–587. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou H, Tan S, Li H and Lin X: Expression
and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
Mol Med Rep. 19:2125–2136. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ratti M, Lampis A, Hahne JC, Passalacqua R
and Valeri N: Microsatellite instability in gastric cancer:
Molecular bases, clinical perspectives, and new treatment
approaches. Cell Mol Life Sci. 75:4151–4162. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yang G: Microsatellite
instability/mismatch repair deficiency and activation of the
Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the
fundic gland: A case report. Medicine (Baltimore).
101(e30311)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lei YY, Huang JY, Zhao QR, Jiang N, Xu HM,
Wang ZN, Li HQ, Zhang SB and Sun Z: The clinicopathological
parameters and prognostic significance of HER2 expression in
gastric cancer patients: A meta-analysis of literature. World J
Surg Oncol. 15(68)2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Batistatou A, Doukas M, Baltogiannis G,
Panelos J, Kamina S, Charalabopoulos K and Agnantis NJ: Early
gastric carcinoma with oncocytic features and extensive metastases.
Pathol Res Pract. 203:539–541. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mavroeidis VK, Gkegkes ID, Saffioti F,
Kandilaris K, Alexiou K, Horti M, Economou N and Demonakou M:
Parietal cell/oncocytic gastric carcinoma: Systematic review and
first-time assessment of HER2 status in two new cases. Ann R Coll
Surg Engl. 102:300–307. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ke B, Wang XN, Liu N, Li B, Wang XJ, Zhang
RP and Liang H: Sonic Hedgehog/Gli1 signaling pathway regulates
cell migration and invasion via induction of
epithelial-to-mesenchymal transition in gastric cancer. J Cancer.
11:3932–3943. 2020.PubMed/NCBI View Article : Google Scholar
|
